Head & Neck Cancer News | Throat & Mouth Cancer Articles

Head and Neck Cancer News

HEAD AND NECK CANCER ADVISOR

Head and Neck Cancer News

FDA_new indication

Gardasil 9 Approved to Prevent Certain HPV-Related Head and Neck Cancers

The FDA has approved an expanded indication for Gardasil 9® (human papillomavirus 9-valent vaccine [HPV], recombinant; Merck) to include the prevention of oropharyngeal and other head and neck cancers caused by HPV Types 16, 18, 31, 33, 45, 52, and 58 in patients aged 9 to 45 years.